Dear Sir/Madam:
RE: FDA-2011-D-0514
Attached please find comments of the Medical Imaging & Technology Alliance (MITA) in response to the draft guidance, as announced in 76 Federal Register 50740, August 16, 2011, "Procedures for Handling Section 522 Postmarket Surveillance Studies."
If you have any questions, please contact me at 703 841 - 3248 or by email at reaton@medicalimaging.org.
Sincerely,
Richard M. Eaton,
Industry Manager,
Medical Imaging & Technology Alliance (MITA)
Attachments:
Medical Imaging and Technology Alliance MITA Comment
Title: Medical Imaging and Technology Alliance MITA Comment
Medical Imaging & Technology Alliance (MITA) - Comment
This is comment on Notice
Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies
View Comment
Attachments:
Medical Imaging and Technology Alliance MITA Comment
Title:
Medical Imaging and Technology Alliance MITA Comment
Related Comments
View AllPublic Submission Posted: 11/16/2011 ID: FDA-2011-D-0514-0003
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0004
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0005
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0007
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0008
Nov 14,2011 11:59 PM ET